Monthly Archives: June 2013

RGRX – penny stock with approaching financial deadline

Very seldom does a penny stock interest us, but we are intrigued by the potential now offered by RGRX.  Regenerx Biopharmaceutical is an early developer of applications for synthetic Thymosin Beta-4, a natural occurring peptide. RGRX  acquired the rights to … Continue reading

Posted in Stock Analysis | Leave a comment